Skip Navigation

European Heart Journal 2001 22(11):903-918; doi:10.1053/euhj.2000.2372
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tabibiazar, R
Right arrow Articles by Rockson, S.G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tabibiazar, R
Right arrow Articles by Rockson, S.G
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Reviews

Angiogenesis and the ischaemic heart

R Tabibiazar and S.G Rocksonf1

Department of Medicine, Stanford University School of Medicine, Stanford, U.S.A.

Received March 13, 2000; accepted July 12, 2000

Key Words: Therapeutic angiogenesis, ischaemia, gene therapy

f1 Correspondence: Stanley G. Rockson, MD, Chief, Consultative Cardiology, Director, Stanford Program for Atherosclerosis and Cardiovascular Therapies, Division of Cardiovascular Medicine, Stanford University School of Medicine, U.S.A.

References

  1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182–1186[Web of Science][Medline]
  2. Folkman J. Tumor angiogenesis. Adv Can Res. 1985;43:175–203
  3. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671–674[CrossRef][Medline]
  4. Risau W. Embryonic angiogenesis factors. Pharmacol Therapeutics. 1991;51:371–376[CrossRef][Web of Science][Medline]
  5. Simons M, Ware JA. Food for starving hearts [comment]. Nature Med. 1996;2:519–520[CrossRef][Web of Science][Medline]
  6. Ware JA, Simons M. Angiogenesis in ischemic heart disease. Nature Med. 1997;3:158–164[CrossRef][Web of Science][Medline]
  7. Rakusan K. Coronary angiogenesis. From morphometry to molecular biology and back. Ann NY Acad Sci. 1995;752:257–266[Web of Science][Medline]
  8. Tomanek RJ. Exercise-induced coronary angiogenesis: a review. Med Sci Sports Exercise. 1994;26:1245–1251[Web of Science][Medline]
  9. Hudlicka O, Brown M, Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol Rev. 1992;72:369–417[Free Full Text]
  10. Hudlicka O, Brown MD, Walter H, Weiss JB, Bate A. Factors involved in capillary growth in the heart. Mol Cell Biochem. 1995;147:57–68[CrossRef][Web of Science][Medline]
  11. Gibaldi M. Regulating angiogenesis: a new therapeutic strategy. J Clin Pharmacol. 1998;38:898–903[Abstract]
  12. Schaper W, Ito WD. Molecular mechanisms of coronary collateral vessel growth. Circ Res. 1996;79:911–919[Free Full Text]
  13. Nagel T, Resnick N, Atkinson WJ, Dewey CF Jr., Gimbrone MA Jr. Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest. 1994;94:885–891[Web of Science][Medline]
  14. Shen H, Clauss M, Ryan J. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood. 1993;81:2767–2773[Abstract/Free Full Text]
  15. Clauss M, Gerlach M, Gerlach H. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med. 1990;172:1535–1545[Abstract/Free Full Text]
  16. Ando J, Nomura H, Kamiya A. The effect of fluid shear stress on the migration and proliferation of cultured endothelial cells. Microvasc Res. 1987;33:62–70[CrossRef][Web of Science][Medline]
  17. Ando J, Kamiya A. Flow-dependent regulation of gene expression in vascular endothelial cells. Jap Heart J. 1996;37:19–32[Medline]
  18. Li J, Hampton T, Morgan JP, Simons M. Stretch-induced VEGF expression in the heart. J Clin Invest. 1997;100:18–24[Web of Science][Medline]
  19. Zheng W, Brown MD, Brock TA, Bjercke RJ, Tomanek RJ. Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor. Circ Res. 1999;85:192–198[Abstract/Free Full Text]
  20. Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Nat Acad Sci USA. 1995;92:768–772[Abstract/Free Full Text]
  21. Kuwabara K, Ogawa S, Matsumoto M. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Nat Acad Sci USA. 1995;92:4606–4610[Abstract/Free Full Text]
  22. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843–845[CrossRef][Medline]
  23. Namiki A, Brogi E, Kearney M. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem. 1995;270:31189–31195[Abstract/Free Full Text]
  24. Fischer S, Sharma HS, Karliczek GF, Schaper W. Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine. Brain Res. Mol Brain Res. 1995;28:141–148[Medline]
  25. Semenza GL, Agani F, Iyer N. Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1. Ann NY Acad Sci. 1999;874:262–268[CrossRef][Web of Science][Medline]
  26. Morris PB, Ellis MN, Swain JL. Angiogenic potency of nucleotide metabolites: potential role in ischemia-induced vascular growth. J Mol Cell Cardiol. 1989;21:351–358[CrossRef][Web of Science][Medline]
  27. Takagi H, King GL, Ferrara N, Aiello LP. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci. 1996;37:1311–1321[Abstract/Free Full Text]
  28. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol. 1996;270:H1803–1811[Medline]
  29. Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest. 1995;95:1798–1807[Web of Science][Medline]
  30. Brogi E, Schatteman G, Wu T. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest. 1996;97:469–476[Web of Science][Medline]
  31. Tomanek RJ, Ratajska A, Kitten GT, Yue X, Sandra A. Vascular endothelial growth factor expression coincides with coronary vasculogenesis and angiogenesis. Dev Dynamics. 1999;215:54–61[CrossRef][Web of Science][Medline]
  32. Schultz A, Lavie L, Hochberg I. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation. 1999;100:547–552[Abstract/Free Full Text]
  33. Sunderkotter C, Beil W, Roth J, Sorg C. Cellular events associated with inflammatory angiogenesis in the mouse cornea. Am J Pathol. 1991;138:931–939[Abstract]
  34. Sunderkotter C, Goebeler M, Schulze-Osthoff K, Bhardwaj R, Sorg C. Macrophage-derived angiogenesis factors. Pharmacol Ther. 1991;51:195–216[CrossRef][Web of Science][Medline]
  35. Polverini PJ. Cellular adhesion molecules. Newly identified mediators of angiogenesis. Am J Pathol. 1996;148:1023–1029[Web of Science][Medline]
  36. Folkman J. Tumor angiogenesis. Mendelsohn J, Howley P, Israel M, Liotta L. The Molecular Basis of Cancer. Philadelphia: W. B. Saunders; 1995. p. 206–232
  37. Schaper W. Control of coronary angiogenesis. Eur Heart J. 1995;16:66–68[Abstract]
  38. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Comm. 1992;189:824–831[CrossRef][Web of Science][Medline]
  39. Goto F, Goto K, Weindel K, Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels [see comments]. Lab Invest. 1993;69:508–517[Web of Science][Medline]
  40. Peters KG, De Vries C, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Nat Acad Sci USA. 1993;90:8915–8919[Abstract/Free Full Text]
  41. Westernacher D, Schaper W. A novel heart derived inhibitor of vascular cell proliferation. Purification and biological activity. J Mol Cell Cardiol. 1995;27:1535–1543[CrossRef][Web of Science][Medline]
  42. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis [see comments]. N Engl J Med. 1995;333:1757–1763[Free Full Text]
  43. Folkman J. What is the role of endothelial cells in angiogenesis? Lab Invest. 1984;51:601–604[Web of Science][Medline]
  44. Svet-Moldavsky GJ, Chimishkyan KL. Tumour angiogenesis factor for revascularisation in ischaemia and myocardial infarction [letter]. Lancet. 1977;1:913[Medline]
  45. Kumar S, West D, Shahabuddin S. Angiogenesis factor from human myocardial infarcts. Lancet. 1983;2:364–368[Web of Science][Medline]
  46. Folkman J, Klagsburn M. Angiogenic factors. Science. 1987;235:442–447[Abstract/Free Full Text]
  47. Klagsbrun M, D'Amore PA. Regulators of angiogenesis. Ann Rev Physiol. 1991;53:217–239[CrossRef][Web of Science][Medline]
  48. Klagsbrun M. Angiogenic factors: regulators of blood supply-side biology. FGF, endothelial cell growth factors and angiogenesis: a keystone symposium, Keystone, CO, USA, April 1–7, 1991. New Biologist. 1991;3:745–749[Web of Science][Medline]
  49. Engelmann GL, Dionne CA, Jaye MC. Acidic fibroblast growth factor and heart development. Role in myocyte proliferation and capillary angiogenesis. Circ Res. 1993;72:7–19[Abstract/Free Full Text]
  50. Sharma HS, Wunsch M, Brand T, Verdouw PD, Schaper W. Molecular biology of the coronary vascular and myocardial responses to ischemia. J Cardiovasc Pharmacol. 1992;20:S23–31[CrossRef]
  51. Scheinowitz M, Abramov D, Eldar M. The role of insulin-like and basic fibroblast growth factors on ischemic and infarcted myocardium: a mini review. Int J Cardiol. 1997;59:1–5[CrossRef][Web of Science][Medline]
  52. Ishikawa F, Miyazono K, Hellman U. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature. 1989;338:557–562[CrossRef][Medline]
  53. Friesel RE, Maciag T. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J. 1995;9:919–925[Abstract]
  54. Wadzinski MG, Folkman J, Sasse J, Devey K, Ingber D, Klagsbrun M. Heparin-binding angiogenesis factors: detection by immunological methods. Clin Physiol Biochem. 1987;5:200–209[Web of Science][Medline]
  55. Klagsbrun M. The fibroblast growth factor family: structural and biological properties. Prog Growth Factor Res. 1989;1:207–235[CrossRef][Medline]
  56. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I. A heparin-binding angiogenic protein—basic fibroblast growth factor—is stored within basement membrane. Am J Pathol. 1988;130:393–400[Abstract]
  57. Ledoux D, Gannoun-Zaki L, Barritault D. Interactions of FGFs with target cells. Prog Growth Factor Res. 1992;4:107–120[CrossRef][Medline]
  58. Xu X, Weinstein M, Li C, Deng C. Fibroblast growth factor receptors (FGFRs) and their roles in limb development. Cell Tissue Res. 1999;296:33–43[CrossRef][Web of Science][Medline]
  59. Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation. 1994;90:649–652[Abstract/Free Full Text]
  60. Asahara T, Bauters C, Zheng LP. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation. 1995;92:II365–71[Medline]
  61. Lindner V, Reidy MA, Fingerle J. Regrowth of arterial endothelium. Denudation with minimal trauma leads to complete endothelial cell regrowth. Lab Invest. 1989;61:556–563[Web of Science][Medline]
  62. Banai S, Jaklitsch MT, Casscells W. Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ Res. 1991;69:76–85[Abstract/Free Full Text]
  63. Engler DA. Use of vascular endothelial growth factor for therapeutic angiogenesis [editorial; comment]. Circulation. 1996;94:1496–1498[Free Full Text]
  64. Connolly DT, Heuvelman DM, Nelson R. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989;84:1470–1478[Web of Science][Medline]
  65. Connolly DT, Olander JV, Heuvelman D. Human vascular permeability factor. Isolation from U937 cells. J Biol Chem. 1989;264:20017–20024[Abstract/Free Full Text]
  66. Pepper MS, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Comm. 1991;181:902–906[CrossRef][Web of Science][Medline]
  67. Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol. 1992;153:557–562[CrossRef][Web of Science][Medline]
  68. Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol. 1993;265:H586–592[Web of Science][Medline]
  69. Tischer E, Mitchell R, Hartman T. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem. 1991;266:11947–11954[Abstract/Free Full Text]
  70. Paavonen K, Horelli-Kuitunen N, Chilov D. Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively. Circulation. 1996;93:1079–1082[Abstract/Free Full Text]
  71. Olofsson B, Pajusola K, Kaipainen A. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Nat Acad Sci USA. 1996;93:2576–2581[Abstract/Free Full Text]
  72. Joukov V, Kaipainen A, Jeltsch M. Vascular endothelial growth factors VEGF-B and VEGF-C. J Cell Physiol. 1997;173:211–215[CrossRef][Web of Science][Medline]
  73. Jeltsch M, Kaipainen A, Joukov V. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice [published erratum appears in Science 1997 Jul 25; 277 (5325): 463]. Science. 1997;276:1423–1425[Abstract/Free Full Text]
  74. Oh SJ, Jeltsch MM, Birkenhager R. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol (Orlando). 1997;188:96–109
  75. Witzenbichler B, Asahara T, Murohara T. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol. 1998;153:381–394[Abstract/Free Full Text]
  76. Ferrara N, Carver-Moore K, Chen H. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439–442[CrossRef][Medline]
  77. Carmeliet P, Ferreira V, Breier G. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996;380:435–439[CrossRef][Medline]
  78. Ferrara N, Heinsohn H, Walder CE, Bunting S, Thomas GR. The regulation of blood vessel growth by vascular endothelial growth factor. Ann NY Acad Sci. 1995;752:246–256[Web of Science][Medline]
  79. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res. 1994;28:1176–1179[Abstract/Free Full Text]
  80. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood. 1996;87:3336–3343[Abstract/Free Full Text]
  81. Millauer B, Wizigmann-Voos S, Schnurch H. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 1993;72:835–846[CrossRef][Web of Science][Medline]
  82. Takagi H, King GL, Robinson GS, Ferrara N, Aiello LP. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci. 1996;37:2165–2176[Abstract/Free Full Text]
  83. Pertovaara L, Kaipainen A, Mustonen T. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem. 1994;269:6271–6274[Abstract/Free Full Text]
  84. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr Topics Microbiol Immunol. 1999;237:1–30[Web of Science][Medline]
  85. Dobson DE, Kambe A, Block E. 1-Butyryl-glycerol: a novel angiogenesis factor secreted by differentiating adipocytes. Cell. 1990;61:223–230[CrossRef][Web of Science][Medline]
  86. Wilkison WO, Spiegelman BM. Biosynthesis of the vasoactive lipid monobutyrin. Central role of diacylglycerol. J Biol Chem. 1993;268:2844–2849[Abstract/Free Full Text]
  87. BenEzra D. Neovasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants. Am J Ophthalmol. 1978;86:455–461[Web of Science][Medline]
  88. Form DM, Auerbach R. PGE2 and angiogenesis. Proc Soc Exp Biol Med. 1983;172:214–218[CrossRef][Medline]
  89. Benoit H, Jordan M, Wagner H, Wagner PD. Effect of NO, vasodilator prostaglandins, and adenosine on skeletal muscle angiogenic growth factor gene expression. J Appl Physiol. 1999;86:1513–1518[Abstract/Free Full Text]
  90. Gullino PM. Prostaglandins and gangliosides of tumor microenvironment: their role in angiogenesis. Acta Oncologica. 1995;34:439–441
  91. Kull FC Jr., Brent DA, Parikh I, Cuatrecasas P. Chemical identification of a tumor-derived angiogenic factor. Science. 1987;236:843–845[Abstract/Free Full Text]
  92. Teuscher E, Weidlich V. Adenosine nucleotides, adenosine and adenine as angiogenesis factors. Biomed Biochim Acta. 1985;44:493–495[Web of Science][Medline]
  93. Dusseau JW, Hutchins PM, Malbasa DS. Stimulation of angiogenesis by adenosine on the chick chorioallantoic membrane. Circ Res. 1986;59:163–170[Abstract/Free Full Text]
  94. Ethier MF, Chander V, Dobson JG Jr. Adenosine stimulates proliferation of human endothelial cells in culture. Am J Physiol. 1993;265:H131–138[Web of Science][Medline]
  95. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science. 1985;228:1324–1326[Abstract/Free Full Text]
  96. Odedra R, Weiss JB. Low molecular weight angiogenesis factors. Pharmacol Ther. 1991;49:111–124[CrossRef][Web of Science][Medline]
  97. Terrell GE, Swain JL. Indirect angiogenic agents do not release fibroblast growth factors from extracellular matrix. Matrix. 1991;11:108–114[Web of Science][Medline]
  98. Fraser RA, Ellis EM, Stalker AL. Experimental angiogenesis in the chorio-allantoic membrane. Bibliotheca Anatomica. 1979;:25–27
  99. Sparks HV Jr., Bardenheuer H. Regulation of adenosine formation by the heart. Circ Res. 1986;58:193–201[Abstract/Free Full Text]
  100. Picano E, Michelassi C. Chronic oral dipyridamole as a 'novel' antianginal drug: the collateral hypothesis. Cardiovasc Res. 1997;33:666–670[Abstract/Free Full Text]
  101. Doi K, Akaike T, Horie H. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer. 1996;77:1598–1604[Web of Science][Medline]
  102. Lala PK, Orucevic A. Role of nitric oxide in tumor progression: lessons from experimental tumors. Can Metast Rev. 1998;17:91–106
  103. Ziche M. Role of nitric oxide in the angiogenesis of avascular tissue. Osteo Cart. 1999;7:403–405[CrossRef]
  104. Ziche M, Morbidelli L, Masini E. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest. 1994;94:2036–2044[Web of Science][Medline]
  105. Murohara T, Asahara T, Silver M. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101:2567–2578[Web of Science][Medline]
  106. Yanagisawa-Miwa A, Uchida Y, Nakamura F. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science. 1992;257:1401–1403[Abstract/Free Full Text]
  107. Giordano FJ, Ping P, McKirnan MD. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart [see comments]. Nature Med. 1996;2:534–539[CrossRef][Web of Science][Medline]
  108. Lazarous DF, Scheinowitz M, Shou M. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 1995;91:145–153[Abstract/Free Full Text]
  109. Unger EF, Banai S, Shou M. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol. 1994;266:H1588–1595[Web of Science][Medline]
  110. Battler A, Scheinowitz M, Bor A. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium. J Am Coll Cardiol. 1993;22:2001–2006[Abstract]
  111. Horrigan MC, Malycky JL, Ellis SG, Topol EJ, Nicolini FA. Reduction in myocardial infarct size by basic fibroblast growth factor following coronary occlusion in a canine model. Int J Cardiol. 1999;68:S85–91[CrossRef][Web of Science][Medline]
  112. Rosengart TK, Budenbender KT, Duenas M, Mack CA, Zhang QX, Isom OW. Therapeutic angiogenesis: a comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin. J Vasc Surg. 1997;26:302–312[CrossRef][Web of Science][Medline]
  113. Schumacher B, von Specht BU, Haberstroh J, Pecher P. The stimulation of neo-angiogenesis in the ischemic heart by the human growth factor FGF. J Cardiovasc Surg. 1998;39:445–453[Medline]
  114. Schumacher B, Pecher P, von Specht BU, Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease [see comments]. Circulation. 1998;97:645–650[Abstract/Free Full Text]
  115. Sellke FW, Li J, Stamler A, Lopez JJ, Thomas KA, Simons M. Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia. Surgery. 1996;120:182–188[CrossRef][Web of Science][Medline]
  116. Banai S, Jaklitsch MT, Shou M. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 1994;89:2183–2189[Abstract/Free Full Text]
  117. Lazarous DF, Shou M, Scheinowitz M. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation. 1996;94:1074–1082[Abstract/Free Full Text]
  118. Hariawala MD, Horowitz JR, Esakof D. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res. 1996;63:77–82[CrossRef][Web of Science][Medline]
  119. Harada K, Friedman M, Lopez JJ. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol. 1996;270:H1791–1802[Medline]
  120. Mack CA, Patel SR, Schwarz EA. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg. 1998;115:168–176[Abstract/Free Full Text]
  121. Bauters C, Asahara T, Zheng LP. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg. 1995;21:314–324[CrossRef][Web of Science][Medline]
  122. Takeshita S, Pu LQ, Stein LA. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation. 1994;90:II228–34[Medline]
  123. Tsurumi Y, Takeshita S, Chen D. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion [see comments]. Circulation. 1996;94:3281–3290[Abstract/Free Full Text]
  124. Takeshita S, Weir L, Chen D. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem Biophys Res Comm. 1996;227:628–635[CrossRef][Web of Science][Medline]
  125. Takeshita S, Isshiki T, Ochiai M. Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia. Circulation. 1998;98:1261–1263[Abstract/Free Full Text]
  126. Mack CA, Magovern CJ, Budenbender KT. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J Vasc Surg. 1998;27:699–709[CrossRef][Web of Science][Medline]
  127. Friesel R, Burgess WH, Mehlman T, Maciag T. The characterization of the receptor for endothelial cell growth factor by covalent ligand attachment. J Biol Chem. 1986;261:7581–7584[Abstract/Free Full Text]
  128. Thompson JA, Anderson KD, DiPietro JM. Site-directed neovessel formation in vivo. Science. 1988;241:1349–1352[Abstract/Free Full Text]
  129. Dionne CA, Crumley G, Bellot F. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 1990;9:2685–2692[Web of Science][Medline]
  130. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol. 1998;8:529–532[CrossRef][Web of Science][Medline]
  131. Asahara T, Chen D, Takahashi T. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization [see comments]. Circ Res. 1998;83:233–240[Abstract/Free Full Text]
  132. Suri C, McClain J, Thurston G. Increased vascularization in mice overexpressing angiopoietin-1. Science. 1998;282:468–471[Abstract/Free Full Text]
  133. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem. 1998;273:18514–18521[Abstract/Free Full Text]
  134. Penta K, Varner JA, Liaw L, Hidai C, Schatzman R, Quertermous T. Del1 induces integrin signaling and angiogenesis by ligation of alphaVbeta3. J Biol Chem. 1999;274:11101–11109[Abstract/Free Full Text]
  135. Rivard A, Silver M, Chen D. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol. 1999;154:355–363[Abstract/Free Full Text]
  136. Yarom R, Zirkin H, Stammler G, Rose AG. Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material. J Pathol. 1992;166:265–270[CrossRef][Web of Science][Medline]
  137. Shammas NW, Moss AJ, Sullebarger JT, Gutierrez OH, Rocco TA. Acquired coronary angiogenesis after myocardial infarction. Cardiology. 1993;83:212–216[Web of Science][Medline]
  138. Carmeliet P, Ng YS, Nuyens D. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 [see comments]. Nature Med. 1999;5:495–502[CrossRef][Web of Science][Medline]
  139. Isner JM, Losordo DW. Therapeutic angiogenesis for heart failure [news; comment]. Nature Med. 1999;5:491–492[CrossRef][Web of Science][Medline]
  140. Silverstein RL, Nachman RL. Angiogenesis and atherosclerosis. The mandate broadens. Circulation. 1999;100:783–785[Free Full Text]
  141. Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice [see comments]. Circulation. 1999;99:1726–1732[Abstract/Free Full Text]
  142. Couffinhal T, Kearney M, Witzenbichler B. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol. 1997;150:1673–1685[Abstract]
  143. Isner JM. Cancer and atherosclerosis: the broad mandate of angiogenesis [editorial; comment]. Circulation. 1999;99:1653–1655[Free Full Text]
  144. Isner JM, Pieczek A, Schainfeld R. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb [see comments]. Lancet. 1996;348:370–374[CrossRef][Web of Science][Medline]
  145. Mazue G, Bertolero F, Jacob C, Sarmientos P, Roncucci R. Preclinical and clinical studies with recombinant human basic fibroblast growth factor. Ann NY Acad Sci. 1991;638:329–340[Web of Science][Medline]
  146. Rosengart TK, Patel SR, Crystal RG. Therapeutic angiogenesis: protein and gene therapy delivery strategies. J Cardiovasc Risk. 1999;6:29–40[Web of Science][Medline]
  147. Blau HM, Springer ML. Gene therapy—a novel form of drug delivery. N Engl J Med. 1995;333:1204–1207[Free Full Text]
  148. Wilson JM. Adenoviruses as gene-delivery vehicles. N Engl J Med. 1996;334:1185–1187[Free Full Text]
  149. Lee JS, Feldman AM. Gene therapy for therapeutic myocardial angiogenesis: a promising synthesis of two emerging technologies. Nature Med. 1998;4:739–742[CrossRef][Web of Science][Medline]
  150. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306–1309[Abstract/Free Full Text]
  151. Takeshita S, Rossow ST, Kearney M. Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol. 1995;147:1649–1660[Abstract]
  152. Isner JM. Vascular endothelial growth factor: gene therapy and therapeutic angiogenesis. Am J Cardiol. 1998;82:63S–64S[CrossRef][Web of Science][Medline]
  153. Losordo W, Vale P, Isner J. Gene therapy for myocardial angiogenesis. Am Heart J. 1999;138:S132–S141[CrossRef][Web of Science][Medline]
  154. Losordo DW, Vale PR, Symes JF. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation. 1998;98:2800–2804[Abstract/Free Full Text]
  155. Baumgartner I, Pieczek A, Manor O. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia [see comments]. Circulation. 1998;97:1114–1123[Abstract/Free Full Text]
  156. Takeshita S, Gal D, Leclerc G. Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury. J Clin Invest. 1994;93:652–661[Web of Science][Medline]
  157. Takeshita S, Tsurumi Y, Couffinahl T. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest. 1996;75:487–501[Web of Science][Medline]
  158. Pickering JG, Jekanowski J, Weir L, Takeshita S, Losordo DW, Isner JM. Liposome-mediated gene transfer into human vascular smooth muscle cells. Circulation. 1994;89:13–21[Abstract/Free Full Text]
  159. Isner JM, Walsh K, Symes J. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum Gene Ther. 1996;7:959–988[Web of Science][Medline]
  160. Muhlhauser J, Jones M, Yamada I. Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors. Gene Ther. 1996;3:145–153[Web of Science][Medline]
  161. Rosengart TK, Lee LY, Patel SR. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation. 1999;100:468–474[Abstract/Free Full Text]
  162. Laham R, Leimback M, Chronos N. Intracoronary administration of recombinant fibroblast growth factor-2 (rFGF-2) in patients with severe coronary artery disease: results of phase I. J Am Coll Cardiol. 1999;383:871–874
  163. Henry T, Annex B, Azrin M. Double blind, placebo controlled trial of recombinant human vascular endothelial growth factor—the VIVA trial. J Am Coll Cardiol. 1999;:874–874
  164. Laham R, Sellke F, Ware A, Pearlman J, Edelman E, Simons M. Results of a randomized, double-blind, placebo-controlled study of local perivascular basic fibroblast growth factor (bFGF) treatment in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol. 1999;:872–874
  165. Gibson CM, Ryan K, Sparano A. Angiographic methods to assess human coronary angiogenesis. Am Heart J. 1999;137:169–179[CrossRef][Web of Science][Medline]
  166. Takeshita S, Isshiki T, Mori H. Use of synchrotron radiation microangiography to assess development of small collateral arteries in a rat model of hindlimb ischemia. Circulation. 1997;95:805–808[Abstract/Free Full Text]
  167. Folkman J. Therapeutic angiogenesis in ischemic limbs [editorial; comment]. Circulation. 1998;97:1108–1110[Free Full Text]
  168. Cooke JP, Bhatnagar R, Szuba A, Rockson SG. Fibroblast growth factor as therapy for critical limb ischemia: a case report. Vasc Med. 1999;4:89–91[Abstract/Free Full Text]
  169. Sellke FW, Laham RJ, Edelman ER, Pearlman JD, Simons M. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann Thorac Surg. 1998;65:1540–1544[Abstract/Free Full Text]
  170. Vale P, Losordo D, Dunnington C. Direct intramyocardial injection of VEGF results in effective gene transfer for patients with chronic myocardial ischemia. J Am Coll Cardiol. 1999;:873–874
  171. Kornowski R, Bhargava B, Leon MB. Percutaneous transmyocardial laser revascularization: an overview [see comments]. Cathet Cardiovasc Interventions. 1999;47:354–359
  172. Mirhoseini M, Muckerheide M, Cayton MM. Transventricular revascularization by laser. Lasers Surg Med. 1982;2:187–198[Medline]
  173. Mirhoseini M, Cayton MM, Shelgikar S, Fisher JC. Laser myocardial revascularization. Lasers Surg Med. 1986;6:459–461[Web of Science][Medline]
  174. Mirhoseini M, Fisher JC, Cayton M. Myocardial revascularization by laser: a clinical report. Lasers Surg Med. 1983;3:241–245[Medline]
  175. Horvath KA, Cohn LH, Cooley DA. Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg. 1997;113:645–653[Abstract/Free Full Text]
  176. Oesterle SN, Reifart NJ, Meier B, Lauer B, Schuler GC. Initial results of laser-based percutaneous myocardial revascularization for angina pectoris. Am J Cardiol. 1998;82:659–662[CrossRef][Web of Science][Medline]
  177. Pelletier MP, Giaid A, Sivaraman S. Angiogenesis and growth factor expression in a model of transmyocardial revascularization. Ann Thorac Surg. 1998;66:12–18[Abstract/Free Full Text]
  178. Lee LY, Rosengart TK. Transmyocardial laser revascularization and angiogenesis: the potential for therapeutic benefit. Semin Thorac Cardiovasc Surg. 1999;11:29–35[Medline]
  179. Malekan R, Reynolds C, Narula N, Kelley ST, Suzuki Y, Bridges CR. Angiogenesis in transmyocardial laser revascularization. A nonspecific response to injury. Circulation. 1998;98:II62–5[Medline]
  180. Sayeed-Shah U, Mann MJ, Martin J. Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization. J Thorac Cardiovasc Surg. 1998;116:763–769[Abstract/Free Full Text]
  181. Horvath KA. Clinical studies of TMR with the CO2 laser. J Clin Laser Med Surg. 1997;15:281–285[Medline]
  182. Abramov D, Bhatnagar G, Tamariz M, Guru V, Goldman BS. Current status of transmyocardial laser revascularization: review of the literature. Can J Cardiol. 1999;15:303–310[Web of Science][Medline]
  183. Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease [see comments]. N Engl J Med. 1999;341:1021–1028[Abstract/Free Full Text]
  184. Allen KB, Dowling RD, Fudge TL. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina [see comments]. N Engl J Med. 1999;341:1029–1036[Abstract/Free Full Text]
  185. Lange RA, Hillis LD. Transmyocardial Laser Revascularization. N Engl J Med. 1999;341:1075–1076[CrossRef][Web of Science][Medline]
  186. Leclerc G, Gal D, Takeshita S, Nikol S, Weir L, Isner JM. Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries. J Clin Invest. 1992;90:936–944[Web of Science][Medline]
  187. Laham RJ, Simons M, Hung D. Subxyphoid access of the normal pericardium: a novel drug delivery technique. Cathet Cardiovasc Intervent. 1999;47:109–111[CrossRef][Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
S. G. Nir, R. David, M. Zaruba, W.-M. Franz, and J. Itskovitz-Eldor
Human embryonic stem cells for cardiovascular repair
Cardiovasc Res, May 1, 2003; 58(2): 313 - 323.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
P. Menasche
Skeletal muscle satellite cell transplantation
Cardiovasc Res, May 1, 2003; 58(2): 351 - 357.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
D.C Felmeden, A.D Blann, and G.Y.H Lip
Angiogenesis: basic pathophysiology and implications for disease
Eur. Heart J., April 1, 2003; 24(7): 586 - 603.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X. Zhao, X. Lu, and Q. Feng
Deficiency in endothelial nitric oxide synthase impairs myocardial angiogenesis
Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2371 - H2378.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
P Menasche and M Desnos
Cardiac reparation: fixing the heart with cells, new vessels and genes
Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D73 - D81.
[Abstract] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tabibiazar, R
Right arrow Articles by Rockson, S.G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tabibiazar, R
Right arrow Articles by Rockson, S.G
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?